<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03185546</url>
  </required_header>
  <id_info>
    <org_study_id>U54DA031659-06</org_study_id>
    <secondary_id>1U54DA031659-01</secondary_id>
    <nct_id>NCT03185546</nct_id>
  </id_info>
  <brief_title>REN-Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors</brief_title>
  <official_title>Project 2: The Impact of Cigarette Nicotine Content, E-cigarette Nicotine Content, and E-cigarette Flavoring on Smoking Behavior</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Project 2 will evaluate the impact of very low nicotine content cigarettes, e-cigarette
      nicotine content, and e-cigarette flavoring on cigarettes smoked per day, nicotine exposure,
      puff topography, discomfort/dysfunction, other health-related behaviors, nicotine/tobacco
      dependence, biomarkers of tobacco exposure, intention to quit, compensatory smoking, other
      tobacco use, cardiovascular function, and perceived risk. Project 2 will also evaluate
      differences between conditions in compliance with product use and the ability to abstain from
      cigarette smoking when provided a financial incentive for abstinence from combusted tobacco.
      This is not a treatment program for smoking.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cigarettes smoked per day</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Total cigarettes smoked per day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study cigarettes smoked per day</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Study cigarettes smoked per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fagerstrom Nicotine Dependence Scale</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Dependence Measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary subscales from brief WISDM</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Dependence Measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Penn State Smoking Dependence Questionnaire</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Dependence Measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mercapturic Acids</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Measure of toxicant exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first smoking lapse</measure>
    <time_frame>Week 07</time_frame>
    <description>Measure of ability to abstain from smoking</description>
  </secondary_outcome>
  <other_outcome>
    <measure>E-cigarette puffs per day</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>E-cigarette use</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of choices to smoke in preference assessment task</measure>
    <time_frame>Week 00</time_frame>
    <description>Measure of relative reinforcement</description>
  </other_outcome>
  <other_outcome>
    <measure>Purchase Task</measure>
    <time_frame>Week 05</time_frame>
    <description>Measure of relative reinforcement and substitution</description>
  </other_outcome>
  <other_outcome>
    <measure>Predicted Behavior Questionnaire</measure>
    <time_frame>Week 06</time_frame>
    <description>Measure of hypothetical tobacco use</description>
  </other_outcome>
  <other_outcome>
    <measure>Non-study cigarette use</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Measure of compliance</description>
  </other_outcome>
  <other_outcome>
    <measure>Drop-out rate</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Drop-out rate</description>
  </other_outcome>
  <other_outcome>
    <measure>Minnesota Nicotine Withdrawal Scale</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Measure of withdrawal</description>
  </other_outcome>
  <other_outcome>
    <measure>Urge to Use Questionnaire</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Measure of craving</description>
  </other_outcome>
  <other_outcome>
    <measure>Center for Epidemiologic Studies Depression Scale</measure>
    <time_frame>Baseline, Week 06</time_frame>
    <description>Measure of depressive symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Breath Alcohol</measure>
    <time_frame>Baseline - Week 07</time_frame>
    <description>Alcohol use</description>
  </other_outcome>
  <other_outcome>
    <measure>Urine Drug Screen</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Drug use</description>
  </other_outcome>
  <other_outcome>
    <measure>Alcohol Use Questionnaire</measure>
    <time_frame>Baseline-Week 06</time_frame>
    <description>Alcohol use</description>
  </other_outcome>
  <other_outcome>
    <measure>Drug Use Questionnaire</measure>
    <time_frame>Baseline-Week 06</time_frame>
    <description>Drug use</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Weight</description>
  </other_outcome>
  <other_outcome>
    <measure>Penn State E-cigarette Dependence Questionnaire</measure>
    <time_frame>Baseline-Week 06</time_frame>
    <description>E-cigarette dependence</description>
  </other_outcome>
  <other_outcome>
    <measure>Expired Carbon Monoxide</measure>
    <time_frame>Baseline - Week 07</time_frame>
    <description>Measure of smoke exposure</description>
  </other_outcome>
  <other_outcome>
    <measure>Urinary Anatabine Biomarker</measure>
    <time_frame>Baseline -Week 07</time_frame>
    <description>Measure of cigarette exposure</description>
  </other_outcome>
  <other_outcome>
    <measure>Total Nicotine Equivalents</measure>
    <time_frame>Baseline - Week 07</time_frame>
    <description>Measure of nicotine exposure</description>
  </other_outcome>
  <other_outcome>
    <measure>Environmental and Social Influences on Tobacco Use Questionnaire</measure>
    <time_frame>Baseline-Week 06</time_frame>
    <description>Measure of smoking and vaping context</description>
  </other_outcome>
  <other_outcome>
    <measure>Context of Product Use Questionnaire</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Measure of tobacco use context</description>
  </other_outcome>
  <other_outcome>
    <measure>Puff topography</measure>
    <time_frame>Baseline, Week 05</time_frame>
    <description>Measure of smoking and vaping topography</description>
  </other_outcome>
  <other_outcome>
    <measure>Timeline Followback</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Measure of tobacco use, alcohol use, and drug use</description>
  </other_outcome>
  <other_outcome>
    <measure>E-cigarette Utility Questionnaire</measure>
    <time_frame>Baseline-Week 06</time_frame>
    <description>Measure of product expectancy</description>
  </other_outcome>
  <other_outcome>
    <measure>Cigarette and E-cigarette Expectancy Questionnaire</measure>
    <time_frame>Baseline-Week 06</time_frame>
    <description>Measure of product expectancy</description>
  </other_outcome>
  <other_outcome>
    <measure>Cigarette and Product Evaluation Scale</measure>
    <time_frame>Baseline-Week 06</time_frame>
    <description>Measure of product subjective effects</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Heart Rate</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Baseline-Week 07</time_frame>
    <description>Blood Pressure</description>
  </other_outcome>
  <other_outcome>
    <measure>Perceived Health Risk Questionnaire</measure>
    <time_frame>Baseline-Week 06</time_frame>
    <description>Measure of perceived personal health risk</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Baseline- Week 07</time_frame>
    <description>Adverse Events</description>
  </other_outcome>
  <other_outcome>
    <measure>Serious adverse events</measure>
    <time_frame>Baseline- Week 07</time_frame>
    <description>Serious adverse events</description>
  </other_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">480</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>NNC cigarette + moderate nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with normal nicotine content tobacco Spectrum Cigarettes along with moderate nicotine level e-liquid cartridges and can choose from cigarette e-liquid flavors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NNC cigarette + low/0 nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with normal nicotine content tobacco Spectrum Cigarettes along with very low or nicotine-free nicotine level e-liquid cartridges and can choose from cigarette e-liquid flavors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NNC cigarette + moderate nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with normal nicotine content tobacco Spectrum Cigarettes along with moderate nicotine level e-liquid cartridges and can choose from cigarette and non-cigarette e-liquid flavors including tobacco flavors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NNC cigarette + low/0 nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with normal nicotine content tobacco Spectrum Cigarettes along with very low or nicotine-free nicotine level e-liquid cartridges and can choose from cigarette and non-cigarette e-liquid flavors including tobacco flavors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VLNC cigarette + moderate nicotine e-liquid + cigarette flavor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with very low nicotine content tobacco Spectrum Cigarettes along with moderate nicotine level e-liquid cartridges and can choose from cigarette e-liquid flavors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VLNC cigarette + low/0 nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with very low nicotine content tobacco Spectrum Cigarettes along with very low or nicotine-free nicotine level e-liquid cartridges and can choose from cigarette e-liquid flavors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VLNC cigarette + moderate nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with very low nicotine content tobacco Spectrum Cigarettes along with moderate nicotine level e-liquid cartridges and can choose from cigarette and non-cigarette e-liquid flavors including tobacco flavors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VLNC cigarette + low/0 nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with very low or nicotine-free nicotine content tobacco Spectrum Cigarettes along with very low nicotine level e-liquid cartridges and can choose from cigarette and non-cigarette e-liquid flavors including tobacco flavors.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NNC Spectrum Cigarette</intervention_name>
    <description>Participants are provided with normal nicotine content Spectrum Cigarette for 7 weeks</description>
    <arm_group_label>NNC cigarette + moderate nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_label>NNC cigarette + low/0 nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_label>NNC cigarette + moderate nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_label>NNC cigarette + low/0 nicotine e-liquid + variety flavors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VLNC Spectrum Cigarette</intervention_name>
    <description>Participants are provided with very low nicotine content Spectrum Cigarette for 7 weeks</description>
    <arm_group_label>VLNC cigarette + moderate nicotine e-liquid + cigarette flavor</arm_group_label>
    <arm_group_label>VLNC cigarette + low/0 nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_label>VLNC cigarette + moderate nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_label>VLNC cigarette + low/0 nicotine e-liquid + variety flavors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate nicotine level e-liquid</intervention_name>
    <description>Participants are provided with moderate nicotine level e-liquid for 7 weeks</description>
    <arm_group_label>NNC cigarette + moderate nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_label>NNC cigarette + moderate nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_label>VLNC cigarette + moderate nicotine e-liquid + cigarette flavor</arm_group_label>
    <arm_group_label>VLNC cigarette + moderate nicotine e-liquid + variety flavors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low/O nicotine level e-liquid</intervention_name>
    <description>Participants are provided with very low or nicotine-free nicotine level e-liquid for 7 weeks</description>
    <arm_group_label>NNC cigarette + low/0 nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_label>NNC cigarette + low/0 nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_label>VLNC cigarette + low/0 nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_label>VLNC cigarette + low/0 nicotine e-liquid + variety flavors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cigarette flavors</intervention_name>
    <description>Participants can choose e-liquid flavors from a selection of cigarette flavors</description>
    <arm_group_label>NNC cigarette + moderate nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_label>NNC cigarette + low/0 nicotine e-liquid + cigarette flavors</arm_group_label>
    <arm_group_label>VLNC cigarette + moderate nicotine e-liquid + cigarette flavor</arm_group_label>
    <arm_group_label>VLNC cigarette + low/0 nicotine e-liquid + cigarette flavors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cigarette and non-cigarette e-liquid flavors</intervention_name>
    <description>Participants can choose e-liquid flavors from a selection of flavors that includes cigarette and non-cigarette choices</description>
    <arm_group_label>NNC cigarette + moderate nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_label>NNC cigarette + low/0 nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_label>VLNC cigarette + moderate nicotine e-liquid + variety flavors</arm_group_label>
    <arm_group_label>VLNC cigarette + low/0 nicotine e-liquid + variety flavors</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18+

          2. Daily smokers who have tried electronic cigarettes

        Exclusion Criteria:

          1. Unwilling to use research cigarettes or electronic cigarettes as part of the trial

          2. Recent use of illicit drugs (except marijuana)

          3. Breath alcohol level &gt; 0.01 (g/dL)

          4. Pregnant, trying to become pregnant or breastfeeding

          5. CO reading &gt;80 ppm

          6. Systolic BP below 90 mm/Hg or greater than or equal to 160 mm/Hg

          7. Diastolic BP below 50 mm/Hr or greater than or equal to 100 mm/Hg

          8. Heart rate lower than 45 bpm or greater than or equal to 105 bpm

          9. Inability to independently read and comprehend the consent form and other written
             study materials and measures.

         10. Conditions in which participation is likely to post a significant threat to health or
             for which the condition could interfere with the ability of the participant to fully
             participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Donny, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tonya Lane</last_name>
    <phone>336-713-1520</phone>
    <email>edonny@wakehealth.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eric C Donny, PhD</last_name>
  </overall_contact_backup>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2017</study_first_submitted>
  <study_first_submitted_qc>June 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>March 23, 2018</last_update_submitted>
  <last_update_submitted_qc>March 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

